AECOM Home  |  Search & Directories  |  Site Map  


*REduced CarboHydrates Against Resistant Growth Tumors

RECHARGE is a University affiliated, IRB approved clinical trial being conducted at the 
Albert Einstein College of Medicine in New York

You may be eligible to participate in this one month dietary research study if:

You’re an adult with metastatic cancer (breast, colon, uterus, cervix, ovary; others may qualify)
whose cancer has been resistant to chemotherapy, or
you decline chemotherapy or are looking for a break, or you seek an alternative to medicines or therapies due to toxic effects.

Our two principles goals are to determine:

 •Whether a very low carbohydrate diet can help participants reduce the amount of cancer in their bodies (as measured by a PET scan at the beginning and end of the study).

           •Whether participants can feel well while maintaining their weight on a very low carbohydrate diet.

Home Page PictureThis research study is for people with advanced cancers who want to take a break from chemotherapy and have cancers that primarily feed on blood sugar. Examples of such cancers include metastatic breast cancer, colon cancer and many others.

Our intervention consists of a 28 day diet of high protein foods such as fish, poultry, meats, eggs and cheese as well as plenty of vegetables. Participants may eat as much of the high protein foods as they wish and can eat up to two cups of vegetables per day. Participants strictly eliminate carbohydrate-containing foods. These foods include all starches and sweets (breads, pasta, rice, potatoes, cereals, fruit, cakes, candies, soda with sugar, etc.).

For an overview of RECHARGE at a glance see our PRINTABLE QUICK SUMMARY

Or for More Information about RECHARGE click on the links below, or call 718-430-2161

Eligibility Requirements
Study Procedures
Medical References To Studies About Low Carbohydrate Diets And Cancer

     For more information please contact:
     Dr. Eugene Fine Phone: 718-904-2639
Dr. CJ Segal-Isaacson Phone: 718 430 2161

Click here to log in